Key Technologies

'Reverse Phase Protein Arrays' image

Reverse Phase Protein Arrays

Zeptosens is a recognised technology leader and among the first companies to commercialise reverse protein arrays and services. The Zeptosens system allows to profile expression and activation of proteins in the equivalent of only 1- 10 cells. Current applications cover secondary screening of drug candidates, mapping of signalling pathways and networks, biomarker discovery and validation, pharmacodynamic investigations and analysis of in vivo animal models. » read more

'IHC-MARK' image


IHC-MARK: Manual interpretation of immunohistochemistry (IHC) is a subjective, time-consuming process, subject to an inherent intra- and inter-observer variability. Automated image analysis approaches offer the possibility of developing more robust and rapid indicators of IHC staining. OncoMark has created a novel, proprietary image analysis toolkit for assessment of IHC-based markers. » read more

'Positron Emission Tomography' image

Positron Emission Tomography

PET (positron emission tomography)is a nuclear imaging technique that involves the use of radioisotope tracers which can probe disease specific biochemical processes, thus providing functional and metabolic information. Radioisotopes that emit two high-energy photons upon decay are detected by PET scanners, with most PET tracers having relatively short half-lives. While PET has limited spatial resolution, co-registration with CT provides high spatially resolved anatomical information, » read more


IVIS Spectrum Optical Imaging

The IVIS Spectrum optical imaging system allows non-invasive longitudinal monitoring of response to therapy and disease progression by bioluminescent or fluorescence means. This technlogy is capable of imaging up to 5 mice simultaneously and can generate close to full tomographic reconstruction of the animal(s) using the Digital Mouse Atlas allowing bioluminescent and fluorescent reporter molecules to be analyzed in an anatomical context. » read more